![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1444, 2004-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Improving uptake of breast cancer screening worth it in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 456, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Screening for proteinuria warranted in the US?
Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Screening for proteinuria warranted in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 444, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Amiodarone worth it for cardiomyopathy vs ICDs in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 421, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lyme disease vaccine worth its cost in the US?
Inpharma, Vol. 1, Iss. 1282, 2001-01 ,pp. :